A Pipeline Built with Purpose – A Partnering Approach Designed to Fuel Innovation

3:00 PM - 3:45 PM (EDT), Wednesday, June 16, 2021
Search General Info
Search Education
Search Partnering Companies

Over the past five years, Horizon Therapeutics has transformed into a leading, large cap, profitable biotechnology company through a business development strategy that turns the most promising ideas into breakthrough treatments for patients. 
Hear from Horizon's Tim Walbert, chairman, president and chief executive officer and Andy Pasternak, chief strategy officer in a conversation on building a deeply focused pipeline, designed to maximize the full potential and value of medicines through a holistic, life-cycle approach that seeks every opportunity across development stages to deliver breakthrough therapies that change patients’ lives.

Sponsored By
EVP, Chief Strategy Officer
Horizon Therapeutics plc
Chairman, President & CEO
Horizon Therapeutics plc